Rob Dillard

DocwireNews

Since 2012, there has been a steeper decline in prostate-specific antigen (PSA) testing among Black men compared with white counterparts, according to a study published in the Journal of the National Cancer Institute.In this study, researchers assessed men aged 40 to 74 years who self-reported receiving a routine PSA test in the past year. They estimated the odds ratios of undergoing screening by race/ethnicity while adjusting for healthcare factors. The researchers noted that prostate cancer incidence rates and rate ratios (IRRs) by race/ethnicity were estimated using Surveillance, Epidemiology, and End Results registry data, gleaned from 2004 to 2017.According to the results, in 2012,&nbsp;PSA testing frequencies were 32.3% (95% confidence interval [CI], 31.7-32.8) among non-Hispanic white (NHW), 30.3% (95% CI, 28.3-32.3) among non-Hispanic Black (NHB), 21.8% (95% CI, 19.9-23.7) among Hispanics, and 17.7% (95% CI, 14.1-21.3) among Asian/Pacific Islander men. The results showed that the absolute screening rate dropped by 9.5% from 2012 to 2018, with a larger decline observed among Black men (11.6%) juxtaposed to white men (9.3%).&ldquo;The frequency of prostate cancer screening varies by race/ethnicity, and there was a modestly steeper decline in PSA testing among younger NHB men relative to NHW men since 2012. The NHB: NHW IRR for localized prostate cancer modestly increased following 2012,&rdquo; the researchers concluded.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Assessing Racial Variations in PSA Testing

Oncology

Since 2012, there has been a steeper decline in prostate-specific antigen (PSA) testing among Black men compared with white counterparts, according to a study published in the ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe